Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Vote In favor of Your Favored Kind Of Organic product - 2Mother and Stepson Rescued After Being Swept Over 6 Miles in Paddleboarding Mishap
- 3Figure out How to Ascertain the Restitution Time frame for Your Sunlight based chargers
- 4Where You Could Sleep With Snorlax in Japan, From MIMARU’s Pokémon Rooms to Grand Hyatt Tokyo’s Limited Pokémon Suite
- 5Chinese fossils reveal a primordial burst of animal evolution
- Meet ‘NASA Mike,’ who’s done 105,000 handstands around the world
- Illumina unveils dataset to speed up AI-powered drug discovery
- 5 Breakout Stars in Ongoing television Series
- The Latest: Fueling begins as NASA aims to send 1st crew to the moon in 53 years
- Passover under fire: Israelis balance fatigue with cautious hope after month of war
- A Couple of Reasonable Guitars for 2024
- State asks High Court to reject challenge to anti-UNRWA laws ahead of Monday hearing
- Which Film Has the Incomparable Melodic Score?
- Fiber is something most people could use more of. But experts advise caution with 'fibermaxxing'
